Clin2
NCT07313007Possibly a fitRecruiting

Gut bacteria chemicals in fatty liver disease

MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis (MASH)

Part of Digestive system, Hormones & metabolism clinical trials.

This study looks at whether the natural chemicals made by your gut bacteria from the food you eat could affect liver fat and health. If you have MASLD (a fatty liver condition), researchers want to measure these gut-produced substances to better understand the disease.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
24 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You have a diagnosis of MASLD (fatty liver) confirmed by an imaging test in the last year.
  • You are between 18 and 80 years old and have a Body Mass Index between 18 and 30.
  • You do not have diabetes and are not taking any blood sugar-lowering medications.
  • You have very regular bowel movements (every 1 to 2 days).
  • You have not used antibiotics, prebiotics, or probiotics in the last 3 months, and you do not have any active serious illness.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07193927Recruiting· Phase 2
Testing a probiotic mix for fatty liver disease (MASLD)

This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.

Girona, Girona
NCT04873258Recruiting
Test a non-invasive tool to screen for fat-related liver disease

This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.

London, London
NCT07872059Not yet recruiting
Blood test patterns in fatty liver disease

This study looks at blood test results in people with fatty liver disease to find common blood abnormalities. It may help doctors better understand and manage the condition.

NCT06986447Enrolling by invitation
Non-invasive tests for serious liver disease

This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.

Chandler, Arizona
NCT07867574Not yet recruiting
Liver health test validation for fatty liver and fibrosis

This study tests a new blood test to help diagnose fatty liver disease and liver fibrosis. It aims to see how well the test works compared with a liver biopsy. Your participation could help improve diagnosis for others.

Bethesda, Maryland
NCT06386094Recruiting
Fatty Liver Disease and Heart Function Study

This study checks how fatty liver disease (a condition where fat builds up in the liver) affects the heart. If you have this liver condition and are between 18 and 65, you may help doctors understand the link between liver health and heart function.

Chandigarh, Chandigarh

Hear when a new MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.